GLAXO FLOVENT WEANS 88% OF SEVERE ASTHMA PATIENTS FROM ORAL STEROIDS; INHALED STEROID CLEARS FDA ADVISORY CMTE. IN METERED DOSE, DISKHALER FORMULATIONS
Executive Summary
Glaxo Wellcome's Flovent eliminates oral corticosteroid therapy in 88% of severe asthma patients previously taking an average daily dose of 10.2 mg oral prednisone.